Skip to main content

Triumph Capital Management

Position in BMY — Bristol Myers Squibb Co

CIK 1730765 DENVER, CO

Position in BMY

as of Jun 30, 2026 · filed Jul 21, 2026
Position Value
$1,191,466
-$24,202 QoQ
Shares Held
20,678
+3.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#1,070
of 2,506 holders
Holding Since
Jun 2023
12 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in BMY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Triumph Capital Management holds $8,936,522 across 15 Drug Manufacturers - General names. BMY ranks #3 (13.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 BMY
Bristol Myers Squibb Co
This page
20,678 $1,191,466

All Filings in BMY

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,191,466 20,678
2026-03-31 $1,215,668 20,044
2025-12-31 $889,740 16,495
2025-06-30 $573,949 12,399
2025-03-31 $1,599,584 26,227
2024-12-31 $311,758 5,512
2024-09-30 $294,607 5,694
2024-06-30 $665,559 16,026
2024-03-31 $767,951 14,161
2023-12-31 $707,410 13,787
2023-09-30 $300,763 5,182
2023-06-30 $237,766 3,718